Understanding the Therapeutic Approaches for Neuroprotection

Author:

Payal Nazrana1,Sharma Lalit2,Sharma Aditi2,Hobanii Yahya Hosan3,Ahmed Hakami Mashael4,Ali Nemat5,Rashid Summya6,Sachdeva Monika7,Gulati Monica89,Yadav Shivam10,Chigurupati Sridevi1112,Singh Abhiav13,Khan Haroon14,Behl Tapan15

Affiliation:

1. Department of Pharmacy, School of Biotechnology, Shoolini University of Biotechnology and Management Sciences, Solan, Himachal Pradesh, India

2. Department of Pharmacology, School of Pharmaceutical Sciences, Shoolini University, Solan, Himachal Pradesh, India

3. Department of Pharmacy, College of Applied Medical Sciences, Jazan University, Jazan, Saudi Arabia

4. Department of Pharmacy, Jazan University, Jazan, Saudi Arabia

5. Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia

6. Department of Pharmacology & Toxicology, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia

7. Department of Pharmacy, Fatima College of Health Sciences, Al Ain, United Arab Emirates

8. School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab 1444411, India

9. ARCCIM, Faculty of Health, University of Technology, Sydney, Ultimo, NSW 2007, Australia

10. School of Pharmacy, Babu Banarasi Das University, Lucknow, Uttar Pradesh, India

11. Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, Qassim University, Buraydah 52571, Kingdom of Saudi Arabia

12. Department of Biotechnology, Saveetha School of Engineering, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Saveetha Nagar, Thandalam, Chennai 602105, India

13. Department of Pharmacy, Indian Council of Medical Research, New Delhi, India

14. Department of Pharmacy, Abdul Wali Khan University, Mardan 23200, Pakistan

15. Department of Pharmacy, School of Health Sciences and Technology, University of Petroleum and Energy Studies, Bidholi, Dehradun, Uttarakhand, India

Abstract

Abstract: The term “neurodegenerative disorders” refers to a group of illnesses in which deterioration of nerve structure and function is a prominent feature. Cognitive capacities such as memory and decision-making deteriorate as a result of neuronal damage. The primary difficulty that remains is safeguarding neurons since they do not proliferate or regenerate spontaneously and are therefore not substituted by the body after they have been damaged. Millions of individuals throughout the world suffer from neurodegenerative diseases. Various pathways lead to neurodegeneration, including endoplasmic reticulum stress, calcium ion overload, mitochondrial dysfunction, reactive oxygen species generation, and apoptosis. Although different treatments and therapies are available for neuroprotection after a brain injury or damage, the obstacles are inextricably connected. Several studies have revealed the pathogenic effects of hypothermia, different breathed gases, stem cell treatments, mitochondrial transplantation, multi-pharmacological therapy, and other therapies that have improved neurological recovery and survival outcomes after brain damage. The present review highlights the use of therapeutic approaches that can be targeted to develop and understand significant therapies for treating neurodegenerative diseases.

Publisher

Bentham Science Publishers Ltd.

Subject

Drug Discovery,Pharmacology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3